PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
35.97%
Net income growth of 35.97% while Healthcare median is zero at 0.00%. Walter Schloss would note a slight edge that could grow if sustained.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Deferred tax growth of 100.00% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
-6.03%
SBC declines yoy while Healthcare median is 0.00%. Seth Klarman would see a near-term advantage in less dilution unless new hires are needed.
-150.99%
Working capital is shrinking yoy while Healthcare median is -40.43%. Seth Klarman would see an advantage if sales remain robust.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-123.01%
AP shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see better immediate cost coverage if top-line remains intact.
-179.37%
Other WC usage shrinks yoy while Healthcare median is -23.89%. Seth Klarman would see an advantage if top-line is stable or growing.
-42.60%
Other non-cash items dropping yoy while Healthcare median is -4.74%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
-14.43%
Negative CFO growth while Healthcare median is -13.70%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce issuance yoy while Healthcare median is 0.00%. Seth Klarman might see an advantage in preserving per-share value unless expansions are neglected.
No Data
No Data available this quarter, please select a different quarter.